Evidence map›Paper›PMID 30643571›Full record

ArticleLung cancer management2017

The prognostic value of serum and bronchoalveolar lavage levels of adiponectin in advanced non-small-cell lung cancer.

Paraskevi Boura, Dimitra Grapsa, Stylianos Loukides, Maria Angelidou, Konstantina Tsakanika, Nikolaos Syrigos, Ioannis Gkiozos

Abstract read
In one paragraph

Article in Lung cancer management, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Paraskevi BouraOncology Unit GPP, 'Sotiria' General Hospital, Medical School, University of Athens, 11527, Athens, Greece.
Dimitra GrapsaOncology Unit GPP, 'Sotiria' General Hospital, Medical School, University of Athens, 11527, Athens, Greece.
Stylianos LoukidesOncology Unit GPP, 'Sotiria' General Hospital, Medical School, University of Athens, 11527, Athens, Greece.
Maria Angelidou3rd Pulmonary Department, Sismanoglio General Hospital, 15126, Athens, Greece.
Konstantina TsakanikaFlow Cytometry Unit, Sismanoglio General Hospital,15126, Athens, Greece.
Nikolaos SyrigosOncology Unit GPP, 'Sotiria' General Hospital, Medical School, University of Athens, 11527, Athens, Greece.
Ioannis GkiozosOncology Unit GPP, 'Sotiria' General Hospital, Medical School, University of Athens, 11527, Athens, Greece.
Sotiria General Hospital · GRNational and Kapodistrian University of Athens · GRSismanoglio General Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWe aimed to explore the prognostic implications of adiponectin (APN) levels in the serum and bronchoalveolar lavage (BAL) of patients with advanced NSCLC. MATERIALS &

methods29 newly diagnosed patients with stage IV NSCLC were prospectively enrolled. Baseline serum and BAL levels of APN were assayed by ELISA and correlated with various clinicopathological parameters, including overall survival.

resultsNo statistically significant correlations were observed between the serum or BAL levels of APN and the clinicopathological parameters evaluated. The only prognostic factor identified, both by univariate and multivariate survival analyses, was performance status.

conclusionThe results of our cohort failed to reveal any prognostic significance of serum and BAL levels of APN in stage IV NSCLC.

Indexed as

adiponectinbronchoalveolar lavageNSCLCserum

Identifiers

PMID30643571
PMCPMC6310335
OpenAlexW2768439293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.